TL;DR
Worldwide efforts have drastically reduced new HIV infections among children, with some countries nearing elimination. However, funding cuts and healthcare access issues threaten these gains, making the goal of an HIV-free generation still challenging.
Recent data indicates that the number of children born with HIV has decreased significantly over the past three decades, bringing the world closer to an HIV-free generation. However, progress is now threatened by funding reductions and healthcare access challenges, particularly in high-burden countries.
In the 1990s, Uganda and other African nations experienced high rates of mother-to-child HIV transmission, with up to 32,000 new infections annually in Uganda alone. Today, thanks to widespread testing, antiretroviral therapies, and prevention programs, that number has fallen below 5,000 in Uganda, and some countries like Botswana report extremely rare new cases.
Despite these advances, approximately 120,000 children are still infected annually worldwide, mostly during pregnancy, childbirth, or breastfeeding. Many of these children die before age four, with an estimated 75,000 AIDS-related deaths each year. The majority of new infections occur in regions with limited access to testing and treatment, and progress has slowed or reversed in some areas due to reductions in international aid.
Why It Matters
This development matters because reducing childhood HIV infections saves lives and moves the world closer to ending the AIDS epidemic. Achieving an HIV-free generation would mean no new infections among infants, which has profound implications for public health, economic stability, and social equity. However, setbacks threaten to undo years of progress, especially if funding and access issues persist.
OraQuick® HIV Self-Test, Oral Fluid Rapid HIV Test for HIV-1 & HIV-2 Detection, Quick & Easy Pain Free Home Testing Kit with Results in 20 Minutes, Ages 14+
FDA-Approved & Clinically Trusted: The only oral fluid HIV self-test capable to detect both HIV-1 and HIV-2 antibodies….
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Background
During the 1990s, high HIV prevalence in Africa led to hundreds of thousands of infants being born with HIV each year. Global efforts, led by organizations like the Elizabeth Glaser Pediatric AIDS Foundation and supported by US and international funding, have dramatically reduced these numbers. The progress was driven by simple, effective interventions such as routine testing for pregnant women and antiretroviral treatment that prevents transmission. Recent years have seen some setbacks, with aid cuts and healthcare disruptions causing a potential resurgence of new infections in vulnerable populations.
“We are actually confronting what it will take to finish this job. That is profound. That is progress.”
— Doris Macharia, President of the Elizabeth Glaser Pediatric AIDS Foundation
“It takes me back to those days when there was no access to medication, only a disease everyone fears.”
— Ismail Harerimana, community health worker from Uganda
“Sustained aid cuts could lead to 1.1 million additional HIV infections in children between 2024 and 2040.”
— UNAIDS projections
A Clinical Guide to Pediatric HIV: Bridging the Gaps Between Research and Practice
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What Remains Unclear
It is still unclear how widespread the impact of recent aid reductions will be over the next few years, and whether new prevention strategies or drugs like Lenacapavir will be accessible to all at-risk populations. The pace of progress in high-burden countries remains uncertain, especially amid ongoing healthcare disruptions.
HIV prevention drugs for high-risk populations
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What’s Next
Efforts will focus on restoring and increasing funding for HIV prevention and treatment programs, expanding access to testing and antiretroviral therapies, and deploying new prevention drugs. Monitoring and evaluation will be critical to prevent setbacks and move closer to the goal of eliminating new pediatric HIV infections.
50Pcs World AIDS Day Stickers,HIV AIDS Awareness Waterproof Vinyl Decals for Water Bottles Laptop Luggage Cup Computer Mobile Phone(HIV)
50 Pcs Sufficient Quantity, Suitable Sizes: Contains 50 independent stickers, sized 1.96 – 3.15 inches, which can meet…
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
How close are we to eliminating new HIV infections among children?
Significant progress has been made, with some countries nearing elimination, but globally, about 120,000 children still acquire HIV each year, so the goal is still within reach but not yet achieved.
What are the main barriers to ending childhood HIV?
Barriers include limited access to testing and treatment, healthcare infrastructure weaknesses, stigma, and funding reductions that disrupt prevention and care programs.
How does funding affect progress against childhood HIV?
Funding is critical for providing testing, antiretroviral drugs, and prevention strategies. Cuts to foreign aid can lead to fewer services, increased infections, and higher mortality rates among children.
Are new HIV prevention drugs available for pregnant women?
Yes, drugs like Lenacapavir are being rolled out in some regions, offering new hope, but access remains uneven, and widespread availability is still developing.
What can be done to ensure continued progress?
Maintaining and increasing funding, strengthening healthcare systems, expanding testing and treatment access, and deploying new prevention tools are essential steps to prevent setbacks and achieve an HIV-free generation.
